Companies spent more than $1 billion on ads for weight loss and diabetes medicines in 2023, up 51% from the prior year, according to new data. This demonstrates the rush to capture new customers after the success of drugs like Ozempic and Wegovy.
Drugmakers spent over $1 billion on advertisements for weight loss and diabetes treatments in 2023, a 51% increase from the previous year. This data highlights the competition in the market and the popularity of drugs like Ozempic and Wegovy .
Drugmakers Advertisements Weight Loss Diabetes Treatments Market Ozempic Wegovy
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
2024 College Basketball Conference Title Odds - ACC, Big Ten, Big East, Big 12, Pac-12, SECNCAAB college basketball conference tournament title odds and past champions for the ACC, Big Ten, Big East, Big 12, Pac-12 and SEC.
Read more »
New Weight-Loss Drug Amycretin Has Patients Losing 13% of Body Weight in Just 3 MonthsDigital destination for sophisticated men & women. Live your best life with expert tips and news on health, food, sex, relationships, fashion and lifestyle.
Read more »
Everything to Know About Weight Training for Weight Loss, According to ExpertsCertified personal trainer, Natascha Grief, shows you how to perfect your plank.
Read more »
Strength Training: Low Weight High Reps Vs High Weight Low Reps?Stephanie Mansour is a contributing health and fitness writer for TODAY. She is a certified personal trainer, yoga and Pilates instructor and weight-loss coach for women. She hosts “Step It Up with Steph” on PBS. Join her complimentary health and weight-loss challenge and follow her for daily inspiration on Instagram and in her new app.
Read more »
Cramer says Washington's antitrust fights against Big Tech don't hold weightCNBC’s Jim Cramer on Monday told investors he disagrees with the government’s antitrust lawsuits against mega cap tech companies.
Read more »
Medicare can now cover certain weight loss drugs in a big step for patientsMedicare patients can soon get coverage for Novo Nordisk’s Wegovy as long as it is prescribed to reduce their risk of heart attacks and strokes.
Read more »